JM
Jitender Mohan Kalra
About Jitender Mohan Kalra
Data last updated:
Jitender Mohan Kalra is a Director at Janus Biotech India Private Limited (since 2019), Additional Director at Systole Remedies Private Limited (since 2021) and Director at Nyx Pharmaceuticals Private Limited (since 2019), and holds 3 more current directorships. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹146 Cr; the largest is Janus Biotech India Private Limited at ₹76.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Aug 2019 | 2019 | ₹76.55 Cr (FY 2025) | Active | |
| Additional Director | 29 Jun 2021 | 2005 | ₹59.68 Cr (FY 2025) | Active | |
| Director | 23 Aug 2019 | 2019 | ₹6.02 Cr (FY 2024) | Active | |
| Director | 31 Dec 2021 | 2021 | ₹3.82 Cr (FY 2025) | Active | |
| Director | 27 Oct 2025 | 2025 | Active | ||
| Director | 30 Dec 2022 | 2022 | Active |
Board colleagues of Jitender Mohan Kalra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harsimran Singh Kalra | 08445853 | Janus Biotech India Private Limited , Systole Remedies Private Limited and 3 more | Director |
| Ravneet Singh | 08445822 | Janus Biotech India Private Limited , Systole Remedies Private Limited and 3 more | Director |
| Ashok Thakur | 11324034 | Systole Remedies Private Limited | Director |
| Mandeep Singh Kalra | 09240146 | Systole Remedies Private Limited , Iris Prints Private Limited and 1 more | Additional Director |
| Pavneet Singh Kalra | 09239772 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Pawan Kumar | 03336280 | Systole Remedies Private Limited | Person Incharge |
| Ashok Kumar | 08516934 | Nyx Pharmaceuticals Private Limited | Director |
| Gaurav Gabbi | 08516935 | Nyx Pharmaceuticals Private Limited | Director |
| Amandeep Singh Anand | 09453668 | Burgeon Health Series Private Limited | Director |
| Tanish Walia | 11356343 | Iris Prints Private Limited | Director |
| Vansh | 11356344 | Iris Prints Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jitender Mohan Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jitender Mohan Kalra
Jitender Mohan Kalra currently holds 6 directorships: Janus Biotech India Private Limited (Director, since 23 Aug 2019, revenue ₹76.55 Cr (FY 2025)); Systole Remedies Private Limited (Additional Director, since 29 Jun 2021, revenue ₹59.68 Cr (FY 2025)); Nyx Pharmaceuticals Private Limited (Director, since 23 Aug 2019, revenue ₹6.02 Cr (FY 2024)); Burgeon Health Series Private Limited (Director, since 31 Dec 2021, revenue ₹3.82 Cr (FY 2025)); Iris Prints Private Limited (Director, since 27 Oct 2025); and 1 more.
Jitender Mohan Kalra was first appointed on 23 Aug 2019 as Director at Janus Biotech India Private Limited. The most recent appointment on record is 27 Oct 2025 at Iris Prints Private Limited.
The 4 current companies of Jitender Mohan Kalra that report revenue have a combined latest revenue of ₹146 Cr: Janus Biotech India Private Limited ₹76.55 Cr (FY 2025); Systole Remedies Private Limited ₹59.68 Cr (FY 2025); Nyx Pharmaceuticals Private Limited ₹6.02 Cr (FY 2024); Burgeon Health Series Private Limited ₹3.82 Cr (FY 2025).
The current boards of Jitender Mohan Kalra's companies include Harsimran Singh Kalra (Janus Biotech India Private Limited), Ravneet Singh (Janus Biotech India Private Limited), Ashok Thakur (Systole Remedies Private Limited), Mandeep Singh Kalra (Systole Remedies Private Limited), Pavneet Singh Kalra (Systole Remedies Private Limited), Pawan Kumar (Systole Remedies Private Limited), among others.